People-Centric, Innovation-Driven
MicroPort® is all about improving human life through the practical application of innovative science. Our aim is to continually develop leading technologies and products for physicians, with life-saving solutions and treatments for patients.
Over 10,000
hospitals covered globally
300
products released to the market
Over 6,000
employees from over 30 countries
The Patient Always Comes First.
MicroPort® constantly adheres to a people-centric approach to build a leading and globalized healthcare group, where the patient always comes first, in the area of high-technology therapies represented by minimal invasion.
Clinical Solutions
Cure diseases, heal patients
More
Patient Care
Heartfelt care, handholding journey
More
Innovation Windows
More innovation for the industry. We never stop.
More
Leading Total Medical Solutions Provider
Thus far, MicroPort® has released about 300 products to the market, covering 10 major business segments, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine Management), Surgical Devices & Medical Robotics, Urology & Gynecology & Respiratory & Gastroenterology, Aesthetics & Rehabilitation, and In vitro Diagnostics & Medical Imaging.
MicroPort® Global
With a head office in Zhang Jiang Science City in Shanghai, China, MicroPort® possesses a large footprint of major production and R&D facilities across the world, including Shanghai, Suzhou, Jiaxing, Dongguan in China, Memphis in the United States, Clamart in France, Saluggia in Italy, and the Dominican Republic, creating a globalized network of R&D, manufacturing, marketing, and services.
